Ablation of thyroid residues with 30 mCi 131I: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4063-4068

  Pacini, Furio ^a,b   Molinaro, Eleonora ^a,b   Castagna, Maria Grazia ^a,b   Lippi, Francesco ^a,b   Ceccarelli, Claudia ^a,b   Agate, Laura ^a,b   Elisei, Rossella ^a,b   Pinchera, Aldo ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b Department of Endocrinology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IODINE 131; RECOMBINANT THYROTROPIN; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; THYROID CANCER; THYROID CELL; VALIDATION PROCESS;

ADENOCARCINOMA, FOLLICULAR; ADULT; BIOLOGICAL TRANSPORT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM STAGING; RECOMBINANT PROTEINS; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; TREATMENT OUTCOME;

EID: 0036740047     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011918     Document Type: Article

References (26)

1. Maxon 3rd HR, Englaro EE, Thomas S, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer - a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132-1136
2. Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger EL 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937-941
3. Hadjieva T 1986 Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer. Radiobiol Radiother 26:819-824
4. McCowen KD, Adler RA, Ghaed N, Verdon T, Hofeldt FD 1976 Low dose radioiodine thyroid ablation in postsurgical patients with thyroid cancer. Am J Med 61:52-58
5. Mazzaferri E 1997 Thyroid remnant 131-I ablation for papillary and follicular thyroid carcinoma. Thyroid 7:265-271
6. Johansen K, Woodhouse NJY, Odugbesan O 1991 Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer J Nucl Med 32:252-254
7. DeGroot L, Reilly M 1982 Comparison of 30 and 50 mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 96:51-53
8. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896
9. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon 3rd HR, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885
10. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD 2001 Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:619-625
11. David A, Blotta A, Bondanelli M, Rossi R, Roti E, Braverman LE, Busutti L, degli Uberti EC 2001 Serum thyroglobulin concentrations and (131)I wholebody scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. J Nucl Med 42:1470-1475
12. Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, Pacini F 2001 Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol 144:5-11
13. Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C 2000 Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. J Clin Endocrinol Metab 85:3640-3645
14. Dow K, Ferrel B, Anello C 1997 Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7:613-619
15. Vitti P, Martino E, Aghini-Lombardi F, Rago T, Antonangeli L, Maccherini D, Nanni P, Loviselli A, Balestrieri A, Araneo G 1994 Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab 79:600-603
16. 131I in patients with differentiated thyroid carcinoma. Nucl Med Commun 22:1021-1027
17. Samuel AM, Rajashekharrao B 1994 Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery. J Nucl Med 35:1944-1950
18. 131I therapy. Nucl Med Commun 19:341-346
19. Siddiqui A, Edmondson J, Wellman HN, Hamaker RC, Lingeman RE, Park HM, Johnston CC 1981 Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma. Clin Nucl Med 6:158-161
20. Ramanna L, Waxman AD, Brachman MB, Tanasescu DE, Sensel N, Braunstein GD 1985 Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. Clin Nucl Med 10:791-795
21. Ramacciotti C, Pretorius HT, Line BR, Goldman JM, Robbins J 1982 Ablation of nonmalignant thyroid remnant with low dose of radioactive iodine: concise communication. J Nucl Med 23:483-489
22. Snyder J, Gorman C, Scanlon P 1983 Thyroid remnant ablation: questionable pursuit of an III-defined goal. J Nucl Med 24:659-665
23. Comtois R, Thériault C, Del Vecchio P 1993 Assessment of the efficacy of iodine-131 for thyroid ablation. J Nucl Med 34:1927-1930
24. Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson SM 2001 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 11:865-569
25. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T 1997 Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138:2227-2232
26. Park SG, Reynolds JC, Brucker-Davis F, Whatley M, McEllin K, Maxted D, Robbins J, Weintraub BD 1996 Iodine kinetics during 131-I scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs hypothyroidism. J Nucl Med 37:15p-15p